Results 121 to 130 of about 46,304 (223)

Preheparin Serum Lipoprotein Lipase Mass as a Coronary Risk Factor in Patients With Chronic Kidney Disease. [PDF]

Cardiol Res
Hitsumoto T.
europepmc   +1 more source

Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026

Hepatology Research, Volume 56, Issue 6, Page 887-902, June 2026.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, with an increasing number of patients progressing to cirrhosis and hepatocellular carcinoma (HCC). Early identification of individuals at high risk for advanced fibrosis is essential for preventing liver‐related ...
Norio Akuta, Tomomi Kogiso, Kenichi Ikejima, Motoyuki Otsuka, Takumi Kawaguchi, Miwa Kawanaka, Hirokazu Takahashi, Nobuharu Tamaki, Hayato Nakagawa, Hayato Hikita, Hideki Fujii, Kanji Yamaguchi, Masato Yoneda, Kazuyoshi Kon, Akira Uchiyama, Yuya Seko, Sadatsugu Sakane, Ryuta Shigefuku, Naoto Fujiwara, Michihiro Iwaki, Takashi Kobayashi, Takuya Adachi, Yasuto Takeuchi, Tsubasa Tsutsumi, Dan Nakano, Kaoru Shibayama, Noriyo Urata, Hisamitsu Miyaaki, Hidekatsu Kuroda, Masahiro Koseki, Hirohito Sone, Yasuhiro Matsubayashi, Keisuke Kakisaka, Atsushi Takai, Kazuo Notsumata, Masataka Seike, Yoshiyuki Takei, Yoshifumi Takeyama, Susumu Eguchi, Sumio Watanabe, Hajime Isomoto, Hiroshi Yotsuyanagi, Takao Itoi, Tetsuo Takehara, Satoshi Mochida   +44 more
wiley   +1 more source

Reversibly reduced lipoprotein lipase in APOA5 c.553G>T-related hypertriglyceridemia successfully treated with pemafibrate. [PDF]

Endocrinol Diabetes Metab Case Rep
Miyauchi S, Utsunomiya Y, Okamoto M, Akesaka K, Ono K, Hara Y, Miyazaki M, Nakaguchi H, Miyake T, Furukawa S, Ebisui O, Hiasa Y, Matsuura B.   +12 more
europepmc   +1 more source

Imaging the ANGPTL3/8-mediated regulation of lipoprotein lipase in the heart. [PDF]

J Lipid Res, 2023
Yang Y, Jung H, Konrad RJ, Fong LG, Young SG.   +4 more
europepmc   +1 more source

A Qualitative Exploration of Unanticipated Effects Experienced By People With Chronic Obstructive Pulmonary Disease Who Participated in Interventions Designed to Reduce Sedentary Behaviour

Health Expectations, Volume 29, Issue 3, June 2026.
ABSTRACT Introduction This study explored the lived experiences of people with chronic obstructive pulmonary disease (COPD) who participated in interventions designed to reduce the accumulation of sedentary behaviour in prolonged uninterrupted bouts. Methods Ten participants with stable COPD participated in a multi‐component intervention that spanned ...
Fiona Coll, Vinicius Cavalheri, Daniel F. Gucciardi, Kylie Hill   +3 more
wiley   +1 more source

Changes to small RNA expression in macrophages in response to very low-density lipoprotein lipid hydrolysis by lipoprotein lipase and NADPH oxidase inhibition. [PDF]

BMC Res Notes
Tijani MO, Chia EW, Cotter NSM, Peña-Castillo L, Brown RJ.   +4 more
europepmc   +1 more source

Lipoprotein lipase: regulation and role in lipoprotein metabolism [PDF]

Proceedings of the Nutrition Society, 1997
T, Olivecrona, M, Hultin, M, Bergö, G, Olivecrona   +3 more
openaire   +2 more sources

High cholesterol absorption efficiency enhances proatherogenic properties of low‐density lipoprotein particles

Journal of Internal Medicine, Volume 299, Issue 6, Page 711-725, June 2026.
Abstract Background and Aims High cholesterol absorption efficiency is determined by genetic variation in small intestinal sterol transporters and affects one‐third of individuals. Their risk for atherosclerotic cardiovascular disease (ASCVD) is increased compared with low cholesterol absorbers, despite similar serum lipid concentrations.
Katariina Öörni, Lauri Äikäs, Maija Ruuth, Feven Tigistu‐Sahle, Reijo Käkelä, Ingmar Wester, Helena Gylling, Piia Simonen   +7 more
wiley   +1 more source

Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice. [PDF]

Nat Commun
Cabodevilla AG, Izquierdo MC, Basu D, Younis W, Tirumalasetty MB, Miao QR, Nasias D, Kanter JE, Ho TWW, Gjini J, Fisher E, Kim J, Lee WL, Bornfeldt K, Goldberg IJ.   +14 more
europepmc   +1 more source

Beyond GLP‐1: The Cardiometabolic Potential of Dual GLP‐1/GIP Receptor Agonists

iNew Medicine, Volume 2, Issue 2, June 2026.
Chao Xue
wiley   +1 more source